Anticholinergic bronchodilator

This page covers all Anticholinergic bronchodilator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting M3 muscarinic acetylcholine receptor, Muscarinic acetylcholine receptors (M1, M3).

Targets

M3 muscarinic acetylcholine receptor · Muscarinic acetylcholine receptors (M1, M3)

Marketed (2)

• Drug: ipratropium (AtroventTM) · AstraZeneca · Respiratory
  Ipratropium is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the airways to reduce bronchoconstriction and mucus secretion.
• Penehyclidine inhalation · Peking University First Hospital · Respiratory/Pulmonology
  Penehyclidine is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce airway secretions and bronchospasm.